QT Imaging Holdings appointed Julia Albright as chief science officer, effective July 27, 2026.
Albright will lead scientific strategy across R&D and clinical teams, with a focus on quantitative breast imaging and AI image analysis.
She was most recently managing director of the HIT and enterprise solutions unit at Canon Medical Systems USA.
Albright previously held senior roles at GE HealthCare, Amazon Web Services, NextGen Healthcare, CorTechs Labs, Philips, Varian, and Siemens Healthineers.
QTI•
